Global Advanced Molecular Nuclear Imaging Market Size is Poised to Reach USD 9.60 Billion by 2035 | CAGR of 5.42%

Global Advanced Molecular Nuclear Imaging Market Size is Poised to Reach USD 9.60 Billion by 2035

According to a research report published by Spherical Insights & Consulting, the Global Advanced Molecular Nuclear Imaging Market is expected to grow from USD 5.37 billion in 2024 to USD 9.60 billion by 2035, at a CAGR of 5.42% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Advanced Molecular Nuclear Imaging Market Size, Share, and COVID-19 Impact Analysis, By Product (SPECT Systems and Hybrid PET Systems Planar Scintigraphy), By Application (Oncology, Cardiology, Neurology, and Others), By End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Detailed Report Decription Here :  https://www.sphericalinsights.com/reports/advanced-molecular-nuclear-imaging-market 

The advanced molecular nuclear imaging market refers to the worldwide industry encompassing the high-precision, non-invasive diagnostic technologies, specifically PET and SPECT combined with CT or MRI for visualizing biological processes at the cellular level. An increasing need for early disease detection, AI integration, and targeted radiopharmaceuticals is driving the growth of the advanced molecular nuclear imaging market for personalized medicine and improved patient outcomes. Continuous ongoing advancement in precision care to help support early diagnosis, tailored treatments and improved patient outcomes are primarily responsible for driving the market.  An upsurging focus on personalized medicine and early disease detection also contributes to promoting the market demand for tailored healthcare solutions. On the contrary, rising equipment costs and limited availability of trained professionals are challenging the advanced molecular nuclear imaging market.

The SPECT systems segment dominated the market, with a major share of around 56.5% in 2024, and is projected to grow at a substantial CAGR during the forecast period.

Based on the product, the advanced molecular nuclear imaging market is divided into SPECT systems and hybrid PET systems planar scintigraphy. Among these, the SPECT systems segment dominated the market, with a major share of around 56.5% in 2024, and is projected to grow at a substantial CAGR during the forecast period. SPECT (Single Photon Emission Computed Tomography) scan imaging test uses radiotracers and a special camera for taking detailed, 3D pictures inside the body. Its widespread application for cardiovascular, cancers, and neurological disorders are propelling segmental market growth.

The oncology segment accounted for the largest share of around 38.5% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the advanced molecular nuclear imaging market is divided into oncology, cardiology, neurology, and others. Among these, the oncology segment accounted for the largest share of around 38.5% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Molecular imaging, especially when combined with liquid biopsy, enables early localization of disease, such as the appearance of metastases. The precise visualization of tumors and their metabolic activity for enhancing early detection and personalized treatment plans is propelling the segmental market.

The hospitals segment dominated the market with the largest share of around 43.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the advanced molecular nuclear imaging market is divided into hospitals, imaging centers, academic and research centers, and others. Among these, the hospitals segment dominated the market with the largest share of around 43.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Hospitals have extensive resources and infrastructure for integrating sophisticated nuclear imaging systems, which cater to a broad spectrum of medical conditions.

North America is expected to hold the majority share of the global advanced molecular nuclear imaging market during the forecast period.

North America is expected to hold the majority share of around 41.2% in the global advanced molecular nuclear imaging market during the forecast period. The U.S. is holding the largest share within the region, with around 85.0% share, owing to the presence of advanced medical facilities, use of high-end diagnostic imaging systems, and strong clinical research. North America has a robust market ecosystem with advanced products developed by major industrial heavyweights. The region’s increasing demand for nuclear imaging and growing technological advancements are contributing to enhancing the market.     

Asia Pacific is anticipated to grow at the fastest pace of 10.0% CAGR in the global advanced molecular nuclear imaging market during the forecast period. China holds the dominant position in the Asia Pacific advanced molecular nuclear imaging market, accounting for about 14.5% CAGR, driven by the rapid growth in the PET/CT imaging systems, healthcare spending, with an increasing prevalence of cancer & other chronic diseases that need molecular nuclear diagnostics. In the Asia Pacific advanced molecular nuclear imaging market, key trends, including integration of artificial intelligence, thermostatic and nuclear medicine practice in the region, as well as expanded isotope production, plays crucial role. Further, rising diagnostic applications across various diseases like cancer and cardiovascular diseases are primarily propelling the market.  

Major vendors in the global advanced molecular nuclear imaging market are Siemens Healthcare Private Limited, Koninklijke Philips N.V., GENERAL ELECTRIC, Neusoft Corporation, Mediso Ltd., TTG IMAGING SOLUTIONS, CMR Naviscan, SurgicEye GmbH, DDD-Diagnostic A/S, Nordion (Canada) Inc., Cardinal Health, Bracco, Lantheus, Jubilant Pharma Limited, Novartis AG, Byour, and Others.   

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In March 2026, MedGenome announced a majority investment in Mumbai-headquartered Medcare Management Services Pvt. Ltd., a radiology and nuclear medicine company known for its PET-CT and advanced molecular imaging services.

• In January 2026, Sheba to inaugurate Roman Abramovich Theranostics and Nuclear Medicine Center. The 4,700-square-meter facility at Tel Hashomer would include an on-site cyclotron and advanced imaging and targeted-treatment units, the medical center said.

• December 2025, TeamBest Global urged SNMMI Board and President Dr. Prabhu Ethiraj to enhance collaboration for advancing theranostics and expanding cancer diagnosis and treatment choices.

• In October 2025, United Imaging, a global manufacturer of cutting-edge medical imaging technology, showcases its most advanced AI-powered molecular imaging innovations, the uMI Panvivo family and the uMI Panorama family, and highlights the company's strong growth and confidence in the European market.    

• In June 2025, GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging solutions would be on display at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana.  

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Advanced Molecular Nuclear Imaging market based on the below-mentioned segments:

Global Advanced Molecular Nuclear Imaging Market, By Product

• SPECT Systems
• Hybrid PET Systems
• Planar Scintigraphy

Global Advanced Molecular Nuclear Imaging Market, By Application

• Oncology
• Cardiology
• Neurology
• Others

Global Advanced Molecular Nuclear Imaging Market, By End User

• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

 Global Advanced Molecular Nuclear Imaging Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 
CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter